BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 17521944)

  • 21. Leukocyte-poor blood components: issues and indications.
    Lichtiger B; Leparc GF
    Crit Rev Clin Lab Sci; 1991; 28(5-6):387-403. PubMed ID: 1772586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quo vadis haemapheresis. Current developments in haemapheresis.
    Borberg H
    Transfus Apher Sci; 2006 Feb; 34(1):51-73. PubMed ID: 16412691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of RBC apheresis and whole blood donation in allogeneic and autologous blood donors.
    Popovsky MA
    Transfus Apher Sci; 2006 Apr; 34(2):205-11. PubMed ID: 16513425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conventional apheresis therapies: a review.
    Ward DM
    J Clin Apher; 2011; 26(5):230-8. PubMed ID: 21882233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of concurrent collection of in-line filtered platelets and packed red blood cells by multicomponent apheresis with three last-generation apparatuses.
    Picker SM; Radojska SM; Gathof BS
    Vox Sang; 2006 Jul; 91(1):47-55. PubMed ID: 16756601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thrombocyte preparation from whole blood stores. Data on yield and leukocyte contamination].
    Mayer G; Wernet D; Schnaidt M; Sugg U
    Beitr Infusionther Klin Ernahr; 1986; 15():66-74. PubMed ID: 3753415
    [No Abstract]   [Full Text] [Related]  

  • 27. National survey of apheresis activity in Italy (2000).
    De Silvestro G; Marson P; Russo GE; Vicarioto M; Donadel C
    Transfus Apher Sci; 2004 Feb; 30(1):61-71. PubMed ID: 14746823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF).
    Dohan Ehrenfest DM; Rasmusson L; Albrektsson T
    Trends Biotechnol; 2009 Mar; 27(3):158-67. PubMed ID: 19187989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Blood components: indication and notice of transfusion].
    Sekiguchi S
    Nihon Rinsho; 1997 Sep; 55(9):2205-13. PubMed ID: 9301278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reasons for moving toward a patient-centric paradigm of clinical transfusion medicine practice.
    Vamvakas EC
    Transfusion; 2013 Apr; 53(4):888-901. PubMed ID: 22882177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A survey of blood purification techniques.
    Stegmayr BG
    Transfus Apher Sci; 2005 Apr; 32(2):209-20. PubMed ID: 15784456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The future of automated red blood cell collection.
    Smith JW; Gilcher RO
    Transfus Apher Sci; 2006 Apr; 34(2):219-26. PubMed ID: 16513424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complications of donor apheresis.
    Winters JL
    J Clin Apher; 2006 Jul; 21(2):132-41. PubMed ID: 15880355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thrombocytapheresis with the new PLT-30 collection chamber in the CS 3000 Plus cell separator].
    Moog R; Müller N
    Beitr Infusionsther Transfusionsmed; 1994; 32():323-4. PubMed ID: 9480118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006.
    Eder AF; Dy BA; Kennedy JM; Notari Iv EP; Strupp A; Wissel ME; Reddy R; Gibble J; Haimowitz MD; Newman BH; Chambers LA; Hillyer CD; Benjamin RJ
    Transfusion; 2008 Sep; 48(9):1809-19. PubMed ID: 18631167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rates of vaso-vagal reactions among first time teenaged whole blood, double red cell, and plateletpheresis donors.
    Reiss RF; Harkin R; Lessig M; Mascari J
    Ann Clin Lab Sci; 2009; 39(2):138-43. PubMed ID: 19429799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicomponent apheresis blood collection in the United States: current status and future directions.
    Popovsky MA
    Transfus Apher Sci; 2005 Jun; 32(3):299-304. PubMed ID: 15944116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective comparison of high-dose plateletpheresis with the latest apheresis systems on the same donors.
    Picker SM; Radojska SM; Gathof BS
    Transfusion; 2006 Sep; 46(9):1601-8. PubMed ID: 16965590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Leukodepletion of labile blood products].
    Vignon D
    Ann Pharm Fr; 1999 Jan; 57(1):61-7. PubMed ID: 10073051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effectiveness of different methods of blood separation in performing plasma- and cytapheresis].
    Ryzhko VV; Gorodetskiĭ VM; Rogova EM
    Ter Arkh; 1988; 60(5):85-8. PubMed ID: 3175936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.